BCL2L11 and cancer: Since Bim is an important apoptotic regulator and plays a key role in the effect of ERBB-targeting drugs in cancer cells [23,24], we evaluated the neratinib treatment-induced change of Bim expression in SUM190 and SUM149 cell lines.